Pay in 4 interest-free payments of $6.93 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Hospitals also play a critical role in initiating advanced GLP-1 treatment regimens and long-term patient monitoring
Some doctors may prescribe it off-label (for a condition it wasn't approved to treat) to help promote weight loss in people with obesity or overweight
Tirzepatide is approved under two brand names: Mounjaro for type 2 diabetes (FDA May 2022) and Zepbound for chronic weight management (November 2023) and moderate-to-severe obstructive sleep apnoea with obesity (December 2024) 28
Because this is a demonstration program, the process may differ slightly from traditional Part D prescription coverage, but the intent is to keep the experience as simple as possible for beneficiaries
Reduction in Abdominal Fat Abdominal fat is particularly harmful, as its closely linked to heart disease and other chronic conditions
US$ 23.38
US$ 26.82
US$ 27.82
